DeSimone Jill 4
4 · Oncternal Therapeutics, Inc. · Filed Jan 5, 2023
Insider Transaction Report
Form 4
DeSimone Jill
Director
Transactions
- Award
Stock Option
2023-01-04+50,000→ 50,000 totalExercise: $1.04Exp: 2033-01-04→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option vest in 36 equal monthly installments with the first installment vesting on February 4, 2023, subject to the recipient's continued service.